204 related articles for article (PubMed ID: 14770035)
21. The effect of 3-aminobenzamide, an inhibitor of poly-ADP-ribose polymerase, on ischemia/reperfusion damage in rat retina.
Lam TT
Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):241-52. PubMed ID: 9144832
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress-induced poly(ADP-ribosyl)ation in chick limb bud-derived chondrocytes.
Zákány R; Bakondi E; Juhász T; Matta C; Szíjgyártó Z; Erdélyi K; Szabó E; Módis L; Virág L; Gergely P
Int J Mol Med; 2007 Apr; 19(4):597-605. PubMed ID: 17334635
[TBL] [Abstract][Full Text] [Related]
23. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
Tramontano F; Malanga M; Quesada P
Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
[TBL] [Abstract][Full Text] [Related]
24. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.
Szijártó A; Batmunkh E; Hahn O; Mihály Z; Kreiss A; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Geró D; Szabó C; Kupcsulik P
J Surg Res; 2007 Sep; 142(1):72-80. PubMed ID: 17612561
[TBL] [Abstract][Full Text] [Related]
25. Continuous inhibition of poly(ADP-ribose) polymerase does not reduce reperfusion injury in isolated rat heart.
Nishizawa K; Yanagida S; Yamagishi T; Takayama E; Bessho M; Kusuhara M; Adachi T; Ohsuzu F
J Cardiovasc Pharmacol; 2013 Jul; 62(1):99-105. PubMed ID: 23846805
[TBL] [Abstract][Full Text] [Related]
26. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
[TBL] [Abstract][Full Text] [Related]
27. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
Kaundal RK; Shah KK; Sharma SS
Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310
[TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose) polymerase and renal hypothermic preservation injury.
Mangino MJ; Ametani M; Szabó C; Southard JH
Am J Physiol Renal Physiol; 2004 May; 286(5):F838-47. PubMed ID: 15075179
[TBL] [Abstract][Full Text] [Related]
30. Intrinsic presence of poly (ADP-ribose) is significantly increased in malignant prostate compared to benign prostate cell lines.
McNealy T; Frey M; Trojan L; Knoll T; Alken P; Michel MS
Anticancer Res; 2003; 23(2B):1473-8. PubMed ID: 12820412
[TBL] [Abstract][Full Text] [Related]
31. Myocardial ischemia and reperfusion reduce the levels of cyclic ADP-ribose in rat myocardium.
Ge ZD; Li PL; Chen YF; Gross GJ; Zou AP
Basic Res Cardiol; 2002 Jul; 97(4):312-9. PubMed ID: 12111041
[TBL] [Abstract][Full Text] [Related]
32. Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation.
Szabó G; Soós P; Heger U; Flechtenmacher C; Bährle S; Zsengellér Z; Szabó C; Hagl S
Eur J Cardiothorac Surg; 2005 Feb; 27(2):226-34. PubMed ID: 15691675
[TBL] [Abstract][Full Text] [Related]
33. Poly(ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury.
Khandoga A; Enders G; Biberthaler P; Krombach F
Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G553-60. PubMed ID: 12181167
[TBL] [Abstract][Full Text] [Related]
34. Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay.
Gerö D; Módis K; Nagy N; Szoleczky P; Tóth ZD; Dormán G; Szabó C
Int J Mol Med; 2007 Nov; 20(5):749-61. PubMed ID: 17912470
[TBL] [Abstract][Full Text] [Related]
35. Improved poststorage cardiac function by poly (ADP-ribose) polymerase inhibition: role of phosphatidylinositol 3-kinase Akt pathway.
Gao L; Kwan JC; Macdonald PS; Yang L; Preiss T; Hicks M
Transplantation; 2007 Aug; 84(3):380-6. PubMed ID: 17700164
[TBL] [Abstract][Full Text] [Related]
36. Distribution of Poly(ADP-ribosyl)ation and cell death after cerebral ischemia in the neonatal rat.
Joly LM; Benjelloun N; Plotkine M; Charriaut-Marlangue C
Pediatr Res; 2003 May; 53(5):776-82. PubMed ID: 12621128
[TBL] [Abstract][Full Text] [Related]
37. Role of poly (ADP) ribose synthetase in lung ischemia-reperfusion injury.
Woolley SM; Farivar AS; Naidu BV; Salzman A; Szabo C; Thomas R; Fraga C; Mulligan MS
J Heart Lung Transplant; 2004 Nov; 23(11):1290-6. PubMed ID: 15539128
[TBL] [Abstract][Full Text] [Related]
38. The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat.
Mota-Filipe H; Sepodes B; McDonald MC; Cuzzocrea S; Pinto R; Thiemermann C
Med Sci Monit; 2002 Nov; 8(11):BR444-53. PubMed ID: 12444369
[TBL] [Abstract][Full Text] [Related]
39. A poly(ADP-ribose) synthetase inhibitor, benzamide protects smooth muscle cells but not endothelium against ischemia/reperfusion injury in isolated guinea-pig heart.
Jakubowski A; Lomnicka M
Acta Biochim Pol; 2007; 54(1):199-204. PubMed ID: 17369883
[TBL] [Abstract][Full Text] [Related]
40. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.
Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT
J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
